carvacrol has been researched along with Diabetes Mellitus, Type 2 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, J; Fan, YQ; Lao, GJ; Lin, DZ; Liu, J; Liu, ZP; Ren, M; Sun, K; Wang, C; Wang, JH; Wang, XY; Yan, L; Zhu, GB | 1 |
| Chen, Y; Deng, C; Han, Q; Xu, H; Zhao, W | 1 |
| Chen, L; Chen, Y; Deng, C; Han, Q; Li, S; Wu, Q; Zhao, W; Zhou, H | 1 |
| Ezhumalai, M; Pugalendi, KV; Radhiga, T | 1 |
4 other study(ies) available for carvacrol and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Potential Novel Serum Metabolic Markers Associated With Progression of Prediabetes to Overt Diabetes in a Chinese Population.
Topics: Aged; Asian People; China; Cymenes; Diabetes Mellitus, Type 2; Disease Progression; Female; Humans; Inosine; Logistic Models; Male; Metabolomics; Middle Aged; Multivariate Analysis; Prediabetic State; Reproducibility of Results | 2021 |
Carvacrol may alleviate vascular inflammation in diabetic db/db mice.
Topics: Animals; Anti-Inflammatory Agents; Cell Survival; Cells, Cultured; Cymenes; Diabetes Mellitus, Type 2; Disease Models, Animal; Endothelial Cells; Glucose Tolerance Test; Inflammation; Insulin; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Random Allocation; Signal Transduction | 2020 |
Protective effect of carvacrol on liver injury in type 2 diabetic db/db mice.
Topics: Animals; Antigens, CD; Blood Glucose; Cymenes; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Insulin Receptor Substrate Proteins; Insulin Resistance; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Protective Agents; Proto-Oncogene Proteins c-akt; Receptor, Insulin; Signal Transduction; Toll-Like Receptor 4 | 2021 |
Antihyperglycemic effect of carvacrol in combination with rosiglitazone in high-fat diet-induced type 2 diabetic C57BL/6J mice.
Topics: Animals; Biomarkers; Blood Glucose; Body Weight; Cymenes; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glycated Hemoglobin; Glycogen; Hypoglycemic Agents; Liver; Male; Mice; Mice, Inbred C57BL; Monoterpenes; Rosiglitazone; Thiazolidinediones | 2014 |